Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Placebo-Controlled, Four- Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-5788 in Healthy Adult Volunteers

Trial Profile

A Randomized, Double-blind, Placebo-Controlled, Four- Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-5788 in Healthy Adult Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Jan 2019

At a glance

  • Drugs ONO-5788 (Primary) ; Octreotide
  • Indications Acromegaly
  • Focus Adverse reactions; First in man; Proof of concept
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 03 Jan 2019 Planned End Date changed from 25 Jan 2019 to 25 Apr 2019.
    • 03 Jan 2019 Planned primary completion date changed from 25 Jan 2019 to 25 Apr 2019.
    • 05 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top